ThursdaySep 20, 2018 10:58 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Launches Mass Market Hemp-Infused Beverages and Supplements

“Oki” product line includes iced teas and flavored water Nutritional supplements to be sold as capsules and tinctures Hemp extract market projected to reach $2.1 billion by 2020, according to company officials Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), a food and beverage company that produces hemp-infused products, has announced the launch of a new line of drinks and supplements featuring hemp extracts into the mainstream market. According to a company press release (http://cnw.fm/UmR4p), the Oki line of products, which includes food supplements and flavored functional beverages containing active hemp extracts, is to be available in up to 2,400 retail…

Continue Reading

WednesdaySep 19, 2018 11:57 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Grows IP Portfolio with Three More Patents in Australia, Two Notices of Allowance in the US

LXRP receives three new Australian patents and two new notices of allowance from the U.S.  patent office; the company expects to receive corresponding patents by year-end 2018 If issued in both Australia and the U.S., LXRP would then hold 12 issued patents within its first patent family, and it continues to pursue pending application claims in this patent family globally The company, which has filed more than 50 patent applications globally, out-licenses its technology that promotes healthier and faster ingestion methods and lower overall dosing Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), which owns the patented DehydraTECH (trademarked) ingestion technology…

Continue Reading

TuesdaySep 18, 2018 10:56 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Releases Q2 2018 Results

Revenue up by C$1.2 million in Q2 and by overall C$4 million in the first six months of the year Company secures 12-month extraction deals with two leading brands Sunniva takes strides toward increasing vertical integration Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a company that cultivates, processes and distributes cannabis, has announced its second quarter financial results, detailing milestones and achievements both for the second quarter and the first half of 2018 (http://cnw.fm/6rZik). Recapping the company’s developments over the past six months, CEO Dr. Anthony Holler said that Sunniva has moved closer toward its goal of full vertical integration, which…

Continue Reading

MondaySep 17, 2018 12:45 pm

Emerald Health Therapeutics Inc. (TSX.V: EMH) (OTCQX: EMHTF) Expands as Cannabis Supplier and Grows JV Production Facility in Canada

EMHTF named as a cannabis supplier for Newfoundland Labrador Liquor Corporation (NLC) to serve the adult use market of the entire province of Newfoundland and Labrador Pure Sunfarms, in which EMHTF is a 50-50 joint venture partner, has received from Health Canada an amendment permitting it to expand its cannabis production area to 550,000 sq. ft. EMHTF already has supply agreements with the Canadian provinces of British Columbia and Ontario; as a cannabis producer, it is ramping up operating facilities in British Columbia and Quebec Emerald Health Therapeutics Inc. (TSX.V: EMH) (OTCQX: EMHTF) is well positioned in Canada in the…

Continue Reading

MondaySep 17, 2018 12:10 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Building on Key Milestones in Sol-gel Cannabinoid Development

Cannabinoid molecule extraction, quantification mark early successes in PreveCeutical’s drug delivery development process PreveCeutical optimistic about prototypical spray applicators in development for cannabinoid therapies Clinical trials of cannabis-based therapeutics anticipated next year PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is celebrating the achievement of several key milestones in the development of the company’s proprietary Sol-gel program for the nasal delivery of select medications, where those medications can be expected to effectively reach the nervous system in order to accomplish their purposes in treating conditions ranging from anxiety to head concussion injuries, a company officer told market reporting outlet…

Continue Reading

MondaySep 17, 2018 11:35 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Platform Makes Cannabis Consumer Protection Possible

Legal cannabis market likely to be plagued by poor quality control DNAX technology tracks all stages of cannabis supply chain Platform already deployed by biosciences company Liberalization may be bringing cannabis consumption out of the shadows, but large parts of the supply chain remain hidden – an inconspicuous circumstance that poses great risk to consumers. In New Haven, Connecticut, about 100 people overdosed on “synthetic marijuana” recently, and they may have had no idea that their pot was “synthetic.” Synthetic marijuana can be made to look like the real thing. Technology from BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) may…

Continue Reading

ThursdaySep 13, 2018 11:21 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives More Patent Grants and Notices of Allowance

Lexaria’s DehydraTECH™ drug delivery platform promotes healthier ingestion methods The company continues to leverage its technology in new areas Lexaria was recently granted new Australian patents and new notices of allowance Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a leader in enhancing the flavor, bouquet and gastro-intestinal delivery of edible cannabinoid consumer products. It has patents granted in the U.S. and Australia for applications of its DehydraTECH™ technology. Moreover, the company has many patents pending in over 40 nations. Lexaria Bioscience’s business strategy involves expanding the applicability of its technology within and beyond the cannabinoid sector. Recently upgraded to…

Continue Reading

WednesdaySep 12, 2018 11:23 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Delivers Single-Source Accountability in the Cannabis Market

BLOCKStrain is poised to lead the charge in providing accountability and transparency in the multibillion-dollar global cannabis market BLOCKStrain’s solution will help protect the intellectual property of cannabis cultivators – a service greatly needed in the burgeoning industry Pioneering into new market frontiers brings the need for innovation and regulation, and BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) addresses one of the newest and hottest industries in the marketplace – cannabis. BLOCKStrain, a full-service software company, stands out in the market as the developer of the very first integrated blockchain platform designed to register and track cannabis intellectual property from…

Continue Reading

ThursdaySep 06, 2018 11:03 am

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) Rolls Out New Line of Beverages, Expands into Canada

Company launches new line of brain-boosting drinks Improved formulation includes lion’s mane mushroom, credited for positive effects on cognitive decline Clinical trial of Koios drinks underway, results expected soon Global functional beverage market to reach $105.5 billion by 2021 Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF), a developer of products designed to boost brain function and productivity, has launched the first two flavors in a new line of beverages that has been flying off the shelves. Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages…

Continue Reading

ThursdaySep 06, 2018 10:13 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Deploys Winning R&D Strategy

Smaller companies achieve higher R&D productivity Collaboration with academia key to R&D success Diverse projects increase chance of success Big Pharma is losing the game in drug development. A decade ago, McKinsey & Company sounded the alarm, warning that the biopharma industry was afflicted by “diminishing R&D productivity.” Despite a doubling of investment in research and development, approvals of “new molecular entities” had fallen precipitously (http://cnw.fm/x1eTK). Nothing appears to have changed since then. A recent report by Deloitte laments the continued decline of returns on R&D investment. While R&D costs have generally remained the same, product revenues are falling, in part…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977